Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Company News
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Open Book Extracts
Open Book Extracts
Activities:
Ingredients
Trending Articles
Independent testing finds six of twelve top-selling Amazon glutathione supplements fail label claims
Cata-Kor's commissioned HPLC analysis, conducted by ISO 17025-accredited Swift Laboratory, found glutathione content ranging from undetectable to significantly under-labelled...
ClonBio Foods builds commercial-scale facility for native arabinoxylan fibre FibAX
The Hungary site, operational Q2 2027, scales up a low-dose, well-tolerated prebiotic shown to produce three times more short-chain fatty acids than inulin — targeting...
Clinically studied lymph system supplements show promise for improving fluid balance and reducing swelling
PureHealth Research has launched lymphatic support supplements formulated with botanicals such as burdock root, echinacea and dandelion, backed by clinical research for their...
Pop. Fizz. Done: SIRIO Europe launches full FizzyBits portfolio for on-the-go supplementation
From metabolic support to joint care, cognitive focus and iron nutrition, the expanded FizzyBits range brings a new generation of instant fizzy tabs to market
Can food influence gene Activity? Scientists discover dietary "epigenetic pencil"
The findings advance the emerging field of "nutriomics," demonstrating how precision nutrition may help to compensate for inherited genetic predispositions
Upcoming event
World of Plant Extracts Expo 2026
24–26 August 2026 | Exhibition | Xi'an, China
See all
Related Content
Ingredients
Open Book Extracts (OBX) announces founding membership in ONE HEMP
Since the inception of Open Book Extracts (OBX) in 2019, the company has served as a leader in the hemp-based CBD market, prioritising science, safety, and responsible commerce
Ingredients
OBX launches trial for minor cannabinoid formulations
The cannabinoids selected were CBD, CBG, CBC, and CBDV, and the polyphenols selected were Quercetin and Curcumin
Finance
OBX receives strategic investment from Btomorrow Ventures
The two companies have signed a scientific collaboration agreement covering areas of future R&D
Ingredients
Open Book Extracts expands capabilities and management team to boost finished goods manufacturing
The expansion will serve to address increased demand for the company’s product development and manufacturing services
Regulatory
OBX announces results of Phase I toxicology assessment
The company contracted AIBMR Life Sciences to conduct the studies investigating the safety of consuming its CBG, CBN, and CBC products
Ingredients
OBX completes trial of cannabinoids for pain relief
Results from the pain study are expected in late April 2022 and will be announced at that time
Ingredients
Open Book Extracts appoints European sales leadership
In March 2021, OBX became a member of the European Industrial Hemp Association Novel Food Consortium
Subscribe now